A new clinical trial has demonstrated that a specially formulated tomato-soy juice blend significantly reduces systemic inflammation in adults with obesity. The four-week study revealed that the enhanced formulation, containing concentrated plant compounds, outperformed standard tomato juice in reducing key inflammatory markers. Participants consuming the targeted blend showed reductions in tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6), and C-reactive protein (CRP)—all established biomarkers of chronic inflammation associated with metabolic dysfunction. The control group receiving standard tomato juice showed minimal changes, indicating that the specific combination and concentration of plant compounds in the enhanced formulation was responsible for the observed therapeutic effects. These findings suggest that nutritional interventions based on synergistic plant compounds may offer a practical, well-tolerated approach to managing obesity-related inflammatory conditions. Read the full article on GMJ Newsroom.
Was this article helpful?
